MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.
Sign Up to like & getrecommendations! Published in 2021 at "Leukemia research"
DOI: 10.1016/j.leukres.2021.106516
Abstract: BACKGROUND Treatment-free survival (TFS) in chronic myeloid leukemia (CML) is a new goal. This prospective study aims to evaluate imatinib discontinuation's feasibility and safety in patients with deep molecular response MR4 (BCR-ABL1 < 0.01 %… read more here.
Keywords: discontinuation results; median time; relapse; discontinuation ... See more keywords
Early Discontinuation, Results Reporting, and Publication of Pediatric Clinical Trials.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatrics"
DOI: 10.1542/peds.2021-052557
Abstract: BACKGROUND AND OBJECTIVES Unique ethical, epidemiological, and economic factors are barriers to performing research in children. The landscape of pediatric clinical trials, including drivers of completion and timely dissemination of results, is not well understood.… read more here.
Keywords: discontinuation results; pediatric clinical; clinical trials; discontinuation ... See more keywords